Head and neck radiotherapy quality assurance conference for dedicated review of delineated targets and organs at risk: results of a prospective study.

Pub Date : 2023-01-01 Epub Date: 2022-11-04 DOI:10.1017/s1460396922000309
J C Farris, N B Razavian, M K Farris, J D Ververs, B A Frizzell, C M Leyrer, L F Allen, K M Greven, R T Hughes
{"title":"Head and neck radiotherapy quality assurance conference for dedicated review of delineated targets and organs at risk: results of a prospective study.","authors":"J C Farris, N B Razavian, M K Farris, J D Ververs, B A Frizzell, C M Leyrer, L F Allen, K M Greven, R T Hughes","doi":"10.1017/s1460396922000309","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Head and neck (HN) radiotherapy (RT) is complex, involving multiple target and organ at risk (OAR) structures delineated by the radiation oncologist. Site-agnostic peer review after RT plan completion is often inadequate for thorough review of these structures. In-depth review of RT contours is critical to maintain high-quality RT and optimal patient outcomes.</p><p><strong>Materials and methods: </strong>In August 2020, the HN RT Quality Assurance Conference, a weekly teleconference that included at least one radiation oncology HN specialist, was activated at our institution. Targets and OARs were reviewed in detail prior to RT plan creation. A parallel implementation study recorded patient factors and outcomes of these reviews. A major change was any modification to the high-dose planning target volume (PTV) or the prescription dose/fractionation; a minor change was modification to the intermediate-dose PTV, low-dose PTV, or any OAR. We analysed the results of consecutive RT contour review in the first 20 months since its initiation.</p><p><strong>Results: </strong>A total of 208 patients treated by 8 providers were reviewed: 86·5% from the primary tertiary care hospital and 13·5% from regional practices. A major change was recommended in 14·4% and implemented in 25 of 30 cases (83·3%). A minor change was recommended in 17·3% and implemented in 32 of 36 cases (88·9%). A survey of participants found that all (<i>n</i> = 11) strongly agreed or agreed that the conference was useful.</p><p><strong>Conclusion: </strong>Dedicated review of RT targets/OARs with a HN subspecialist is associated with substantial rates of suggested and implemented modifications to the contours.</p>","PeriodicalId":0,"journal":{"name":"","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10827337/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/s1460396922000309","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/11/4 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Head and neck (HN) radiotherapy (RT) is complex, involving multiple target and organ at risk (OAR) structures delineated by the radiation oncologist. Site-agnostic peer review after RT plan completion is often inadequate for thorough review of these structures. In-depth review of RT contours is critical to maintain high-quality RT and optimal patient outcomes.

Materials and methods: In August 2020, the HN RT Quality Assurance Conference, a weekly teleconference that included at least one radiation oncology HN specialist, was activated at our institution. Targets and OARs were reviewed in detail prior to RT plan creation. A parallel implementation study recorded patient factors and outcomes of these reviews. A major change was any modification to the high-dose planning target volume (PTV) or the prescription dose/fractionation; a minor change was modification to the intermediate-dose PTV, low-dose PTV, or any OAR. We analysed the results of consecutive RT contour review in the first 20 months since its initiation.

Results: A total of 208 patients treated by 8 providers were reviewed: 86·5% from the primary tertiary care hospital and 13·5% from regional practices. A major change was recommended in 14·4% and implemented in 25 of 30 cases (83·3%). A minor change was recommended in 17·3% and implemented in 32 of 36 cases (88·9%). A survey of participants found that all (n = 11) strongly agreed or agreed that the conference was useful.

Conclusion: Dedicated review of RT targets/OARs with a HN subspecialist is associated with substantial rates of suggested and implemented modifications to the contours.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
头颈部放射治疗质量保证会议:一项前瞻性研究的结果
目的:头颈部(HN)放疗(RT)是一个复杂的过程,涉及放射肿瘤学家划定的多个靶点和危险器官(OAR)结构。在RT计划完成后,与地点无关的同行评审通常不足以对这些结构进行彻底的评审。深入回顾RT轮廓对于维持高质量的RT和最佳的患者预后至关重要。材料和方法:2020年8月,我院启动了HN RT质量保证会议,每周一次的远程会议,至少有一位放射肿瘤学HN专家参加。在RT计划创建之前,详细审查了目标和桨。一项平行实施研究记录了这些评价的患者因素和结果。主要变化是对高剂量计划目标体积(PTV)或处方剂量/分离的任何修改;一个小的变化是修改中剂量PTV,低剂量PTV或任何OAR。我们分析了自启动以来的前20个月连续RT等高线回顾的结果。结果:共回顾了8个提供者治疗的208例患者:86.5%来自初级三级保健医院,13.5%来自区域诊所。14.4%的人建议进行重大改变,30例中有25例(83.3%)实施了重大改变。有17.3%的患者建议进行轻微的改变,36例中有32例(88.9%)得到了实施。一项对参与者的调查发现,所有人(n = 11)都强烈同意或同意会议是有用的。结论:由HN专科医生对RT靶点/OARs进行专门审查与建议和实施的轮廓修改的实质性率相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1